The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, issue.4, pp.673-751, 2000. ,
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002. ,
DOI : 10.2174/1568011023353714
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice, Investigational ew Drugs, vol.4, issue.3, pp.207-220, 1986. ,
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice, Cancer Treat. Rep, issue.5, pp.70-631, 1986. ,
Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512), British Journal of Cancer, vol.58, issue.3, pp.58-341, 1988. ,
DOI : 10.1038/bjc.1988.215
Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512), British Journal of Cancer, vol.58, issue.2, pp.58-144, 1988. ,
DOI : 10.1038/bjc.1988.181
Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts, British Journal of Cancer, vol.57, issue.3, pp.57-277, 1988. ,
DOI : 10.1038/bjc.1988.59
Differential efficacy of flavone acetic acid against liver versus lung metastases in a human tumour xenograft, British Journal of Cancer, vol.63, issue.1, pp.63-71, 1991. ,
DOI : 10.1038/bjc.1991.15
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization, Cancer Chemother. Pharmacol, issue.3, pp.35-219, 1995. ,
Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma, British Journal of Cancer, vol.60, issue.1, pp.60-104, 1989. ,
DOI : 10.1038/bjc.1989.230
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro, Cancer Chemotherapy and Pharmacology, vol.9, issue.5, pp.24-273, 1989. ,
DOI : 10.1007/BF00304757
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent, Eur. J Cancer Clin. Oncol, issue.10, pp.23-1529, 1987. ,
The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitro, Investigational New Drugs, vol.4, issue.4, pp.289-293, 1986. ,
DOI : 10.1007/BF00173501
In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015), European Journal of Cancer and Clinical Oncology, vol.23, issue.8, pp.23-1135, 1987. ,
DOI : 10.1016/0277-5379(87)90146-5
Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2, J Immunol, issue.10, pp.141-3671, 1988. ,
Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties, Anticancer Res, vol.16, issue.1, pp.425-431, 1996. ,
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy, Cancer Res, issue.17, pp.48-4749, 1988. ,
Reduction of Tumor Blood Flow by Flavone Acetic Acid: A Possible Component of Therapy, JNCI Journal of the National Cancer Institute, vol.81, issue.3, pp.81-216, 1989. ,
DOI : 10.1093/jnci/81.3.216
Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action, European Journal of Cancer and Clinical Oncology, vol.25, issue.10, pp.25-1419, 1989. ,
DOI : 10.1016/0277-5379(89)90099-0
Blood Flow Failure as a Major Determinant in the Antitumor Action of Flavone Acetic Acid, JNCI Journal of the National Cancer Institute, vol.81, issue.13, pp.81-1005, 1989. ,
DOI : 10.1093/jnci/81.13.1005
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo, Cancer Res, issue.5, pp.48-1279, 1988. ,
Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes, Drug Metab Dispos, issue.11, pp.35-2023, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00323880
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, Pharmacogenetics, vol.14, issue.1, pp.14-15, 2004. ,
DOI : 10.1097/00008571-200401000-00001
Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man, Xenobiotica, issue.12, pp.30-1131, 2000. ,
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction, Expert Opinion on Drug Metabolism & Toxicology, vol.283, issue.6, pp.875-894, 2006. ,
DOI : 10.1097/00007890-199810270-00026
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450, Chemico-Biological Interactions, vol.139, issue.1, pp.1-21, 2002. ,
DOI : 10.1016/S0009-2797(01)00285-X
-1-benzopyrans, Synthesis, vol.1990, issue.01, pp.66-70, 1990. ,
DOI : 10.1055/s-1990-26791
URL : https://hal.archives-ouvertes.fr/hal-00747378
Synthesis and in vitro cytotoxicity of a series of 3-aminoflavones, European Journal of Medicinal Chemistry, vol.32, issue.1, pp.3271-82, 1997. ,
DOI : 10.1016/S0223-5234(97)84363-2
Synthesis and Biological Evaluation of Novel Flavone-8-acetic Acid Derivatives as Reversible Inhibitors of Aminopeptidase N/CD13, Journal of Medicinal Chemistry, vol.46, issue.18, pp.46-3900, 2003. ,
DOI : 10.1021/jm021109f
Inhibition of Microsomal Epoxide Hydrolases by Ureas, Amides, and Amines, Chemical Research in Toxicology, vol.14, issue.4, pp.409-415, 2001. ,
DOI : 10.1021/tx0001732
In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids, Food and Chemical Toxicology, vol.40, issue.5, pp.40-609, 2002. ,
DOI : 10.1016/S0278-6915(01)00125-9
Microsomal enzymes involved in toxicology -Analysis and separation. In: Principles and methods of toxicology(Ed. Hayes AW), pp.609-634, 1982. ,
Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme, Cancer Res, issue.15, pp.54-4026, 1994. ,
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chemical Research in Toxicology, vol.4, issue.2, pp.168-179, 1991. ,
DOI : 10.1021/tx00020a008
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture, FASEB J, vol.6, issue.2, pp.752-758, 1992. ,
HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE, Drug Metabolism and Disposition, issue.12, pp.33-1920, 2005. ,
DOI : 10.1124/dmd.105.006866
Use of a novel real-time quantitative reverse transcriptionpolymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver, Drug Metab Dispos, issue.6, pp.28-709, 2000. ,
An in vivo and in vitro comparison of CYP gene induction in mice using liver slices and quantitative RT-PCR, Toxicology in Vitro, vol.20, issue.1, pp.125-131, 2006. ,
DOI : 10.1016/j.tiv.2005.06.040
Sigmoidal curve-fitting redefines quantitative real-time PCR with the prospective of developing automated high-throughput applications. ucleic Acids Res, pp.32-178, 2004. ,
One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler, Analytical Biochemistry, vol.372, issue.1, pp.372-116, 2008. ,
DOI : 10.1016/j.ab.2007.08.023
Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions, Archives of Biochemistry and Biophysics, vol.409, issue.1, pp.59-71, 2003. ,
DOI : 10.1016/S0003-9861(02)00415-0
Metabolism of alpha-naphthoflavone and beta-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems, J. Biol. Chem, issue.9, pp.258-5649, 1983. ,
Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor, Carcinogenesis, vol.20, issue.8, pp.20-1561, 1999. ,
DOI : 10.1093/carcin/20.8.1561
Analysis of structural requirements for ah receptor antagonist activity: Ellipticines, flavones, and related compounds, Biochemical Pharmacology, vol.52, issue.11, pp.52-1787, 1996. ,
DOI : 10.1016/S0006-2952(96)00600-4
Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists, Biochemical Pharmacology, vol.51, issue.8, pp.51-1077, 1996. ,
DOI : 10.1016/0006-2952(96)00063-9
Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver, Toxicol Appl Pharmacol, vol.136, issue.2, pp.348-353, 1996. ,
Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone ?-H2AX, Cancer Res, issue.19, pp.66-9656, 2006. ,